Qinglei Chong | Chemistry | Innovative Research Award

Posted on by Award and Honors

Mr. Qinglei Chong | Chemistry | Innovative Research Award

Associate Professor at Chinese Academy of Sciences, China.

Mr. Qinglei Chong is an accomplished synthetic chemist specializing in asymmetric catalysis and transition metal-based reaction methodologies. With a strong academic foundation from the Chinese Academy of Sciences and postdoctoral mentorship under China’s leading chemists, he has steadily advanced through key research roles at the Shanghai Institute of Organic Chemistry. His contributions are recognized by top-tier journals, and in 2019, he was honored as an Outstanding Postdoctoral Fellow by SIOC. Currently serving as an Associate Researcher, Mr. Chong continues to lead and collaborate on impactful research in metal-catalyzed asymmetric transformations.

Professional Profile

Scopus 

Orcid

🎓 Education 

  • 2005.9 – 2009.6: Bachelor of Science in Chemistry, Nanjing Normal University

  • 2009.9 – 2014.6: Ph.D. (Combined MSc–Ph.D. Program), Dalian Institute of Chemical Physics, Chinese Academy of Sciences

💼 Experience 

  • 2014.9 – 2016.9: Postdoctoral Researcher, Nankai University, under the mentorship of Academicians Qilin Zhou and Kuiling Ding

  • 2016.9 – 2016.12: Assistant Researcher, Shanghai Institute of Organic Chemistry (SIOC), CAS

  • 2016.12 – 2019.4: Postdoctoral Researcher, SIOC, CAS

  • 2019.4 – 2019.9: Assistant Researcher, SIOC, CAS

  • 2019.9 – Present: Associate Researcher, SIOC, CAS

🔬 Research Interests

  • Transition Metal Catalysis

  • Asymmetric Catalytic Methodologies

  • Development of Organometallic Complexes for Selective Synthesis
    Mr. Chong’s research focuses on innovating asymmetric catalytic processes utilizing transition metal catalysts to enable high-selectivity reactions in organic synthesis.

Top Noted Publications:

1. Cobalt-Catalyzed Diastereo- and Enantioselective Reductive Allyl Additions to Aldehydes with Allylic Alcohol Derivatives via Allyl Radical Intermediates

  • Journal: Journal of the American Chemical Society

  • Year: 2021

  • Volume: 143

  • Pages: 12755–12765

  • DOI: 10.1021/jacs.1c05690

  • Summary: This study presents a cobalt-catalyzed method for the diastereo- and enantioselective reductive allyl addition to aldehydes, utilizing allylic alcohol derivatives. The reaction proceeds via allyl radical intermediates, offering a novel approach to construct chiral homoallylic alcohols with high selectivity.ACS Publications+1PubMed+1

2. Chiral Cyclohexyl-Fused Spirobiindanes: Practical Synthesis, Ligand Development, and Asymmetric Catalysis

3. N-Heterocyclic Carbene–Cu-Catalyzed Enantioselective Allenyl Conjugate Addition

4. Cobalt-Catalyzed Atom-Economical, Diastereo- and Enantioselective Coupling of Aldimines and Cyclopropanols

  • Journal: Science China Chemistry

  • Year: 2021

  • Volume: 64

  • Pages: 1750–1755

  • DOI: 10.1007/s11426-021-1062-y

  • Summary: This research describes a cobalt-catalyzed coupling of aldimines and cyclopropanols, achieving high diastereo- and enantioselectivity. The reaction offers an atom-economical route to β-amino ketones, valuable intermediates in organic synthesis.SpringerLink

5. Photoredox/Cobalt-Catalyzed Chemo-, Regio-, Diastereo-, and Enantioselective Reductive Coupling of 1,1-Disubstituted Allenes and Cyclobutenes

Conclusion:

Mr. Qinglei Chong exemplifies the core criteria for the Research for Innovative Research Award in Chemistry: original, high-impact research that pushes synthetic boundaries while addressing real-world chemical challenges. His track record in asymmetric catalysis and transition metal chemistry is both robust and transformative. With growing visibility and continued excellence, he is well-positioned not only to receive the award but to be a future global leader in sustainable synthetic chemistry.

Pharmacology

Posted on by Award and Honors

Introduction to Pharmacology:

Pharmacology is the science that explores the interactions between drugs and biological systems, aiming to understand how drugs work, their mechanisms of action, and their effects on the human body. It plays a central role in the development, evaluation, and safe use of pharmaceuticals to treat diseases, manage symptoms, and improve overall health.

Clinical Pharmacology:

Clinical pharmacology involves the study of drug effects in humans, focusing on dosages, drug interactions, and personalized medicine approaches to optimize therapeutic outcomes.

Pharmacokinetics and Pharmacodynamics:

These subfields investigate the absorption, distribution, metabolism, and excretion of drugs within the body (pharmacokinetics) and their mechanisms of action (pharmacodynamics).

Toxicology:

Toxicology assesses the adverse effects of drugs and chemical substances, helping to identify potential risks and safety concerns associated with drug use.

Pharmacogenomics:

Pharmacogenomics explores the genetic factors influencing an individual’s response to drugs, guiding personalized treatment plans and minimizing adverse reactions.

Drug Development and Regulatory Affairs:

This subfield focuses on the process of bringing new drugs to market, including preclinical testing, clinical trials, and regulatory approvals to ensure drug safety and efficacy.

Pharmacology plays a crucial role in healthcare by providing the knowledge and tools necessary to develop, prescribe, and administer drugs effectively and safely. Understanding these subtopics is essential for healthcare professionals, researchers, and policymakers to make informed decisions regarding drug therapies and patient care